Hospitals Shutting Down Transgender Care for Young Patients Under Federal Pressure

Children's Hospital Los Angeles has stopped offering gender-affirming care to transgender patients, joining a wave of major pediatric medical centers closing these programs as the Trump administration threatens to cut federal funding from institutions that provide such care to minors.

The Verge reports that the Los Angeles facility, which once offered comprehensive services including hormone therapy and mental health support, formally closed its Center for Transyouth Health and Development on July 22, 2025. The closure came after sustained federal pressure campaigns targeting hospitals that treat transgender youth.

The Wave of Program Shutdowns

Kaiser Permanente, one of California's largest providers of healthcare for transgender people, halted surgical gender-affirming care for patients under 19 at its facilities across the state. Connecticut Children's Medical Center and Rady Children's Hospital—California's largest children's hospital system—have also shut down their gender-affirming care programs. Rady ended hormone therapy services for those under 19 as of February 6, 2026.

In Texas, the situation has taken a different turn. Texas Children's Hospital in Houston now faces a federal requirement to create a "detransition clinic"—a facility focused on helping patients reverse earlier gender-affirming treatments rather than providing ongoing care.

The pattern is clear: major hospital systems are closing programs under federal pressure rather than risk funding loss.

How the Federal Government Is Applying Pressure

The Trump administration is using multiple tools to restrict pediatric gender care access. The Department of Health and Human Services, with leadership from RFK Jr. and Dr. Mehmet Oz (who oversees Medicaid and Medicare), has announced regulatory actions targeting federal funding streams that support these services.

The core strategy hinges on money. The administration proposes to cut off Medicaid and Medicare funding—federal insurance programs for low-income and elderly patients—from hospitals that provide gender-affirming care to minors. Because Medicaid funds a significant portion of pediatric care nationwide, this threat carries real weight. The restrictions would imperil access in roughly two dozen states where these treatments remain legal under state law and are funded by Medicaid.

Beyond funding threats, the Department of Justice has pursued direct legal action. It initially demanded that hospitals turn over transgender minors' medical records, though it later withdrew those demands following legal challenges. A federal judge rejected a similar subpoena against Children's Hospital Colorado, and Colorado's state Supreme Court subsequently ruled that the hospital must resume offering gender-affirming care to transgender youth.

Medical Organizations Push Back

Major medical groups have maintained their support for evidence-based transgender care. The American Academy of Pediatrics has published policy statements supporting comprehensive care for transgender children. The Endocrine Society, an organization of hormone specialists, stated that recent research reviews (including the NHS England Cass Review) do not contradict their clinical guidelines on gender-affirming care, and the group is updating its recommendations.

Medical research presents a consistent finding: transgender people denied care show higher rates of suicide and self-harm. Studies indicate that transgender youth with access to pubertal suppression (medication that delays puberty) experience lower rates of suicidal thoughts compared to those who wanted but could not access the treatment. About 70 percent of transgender patients report experiencing mistreatment from medical providers, including harassment.

Conversion therapy—attempts to change someone's gender identity through psychological intervention—remains banned in 20 states and Washington, D.C. Research shows these practices correlate with worse mental health outcomes, including increased suicide risk.

A Familiar Pattern in Federal Healthcare

The broader context here resembles earlier episodes in healthcare policy. Federal agencies have deployed funding leverage to reshape medical practice before—most notably during the Reagan administration's response to HIV/AIDS and during debates over emergency contraception access. The playbook is consistent: threaten core funding streams, pursue legal action against specific institutions, and create enough regulatory uncertainty that hospitals voluntarily comply rather than risk financial loss.

In this author's view, what distinguishes the current moment is the speed and scope of the rollout across multiple states, and the extension of federal leverage into clinical practice standards—an area traditionally left to state medical boards and professional guidelines. That shift may have implications beyond this particular issue.

The Practical Impact on Hospitals

These restrictions create real operational challenges for large health systems. When a hospital system like Kaiser Permanente must segregate pediatric gender care from the rest of its operations to maintain federal reimbursements, it can fracture care delivery. Transgender youth often need coordinated medical attention, mental health support, and social services all working together. Separating these services can make care harder to access and coordinate.

The regulatory uncertainty has also prompted some institutions to shut down programs defensively—before regulations are finalized—rather than wait and navigate changing rules. This reflects a broader healthcare sector concern that federal oversight is expanding beyond its traditional bounds into decisions about which medical treatments hospitals can offer.

As federal enforcement takes effect across multiple states, the landscape for pediatric gender care is becoming a patchwork. Access now depends heavily on which state you live in, how much legal risk your hospital is willing to tolerate, and whether your state's laws protect these services. The long-term effects on medical practice standards and on the balance of power between federal and state healthcare policy remain uncertain as legal challenges move through federal courts.